Rossari Biotech Limited — Important, 25-10-2024: General Updates

Rossari Biotech Limited's board approved the unaudited standalone and consolidated financial results for the half-year ending September 30, 2024, revealing revenue growth and profitability. Mr. Gurudas Aras was appointed as an Additional Non-Executive Independent Director, while Mr. Aseem Dhru's re-appointment was recommended. The company plans to acquire 100% of Unistar Thai Co. Limited’s equity. An Extraordinary General Meeting is scheduled for November 11, 2024, to approve these matters, with a record date of November 4, 2024.